Biotech Rebounds Amid Semiconductor Rally... Rotational Investment Strategy Effective Through Year-End

The pharmaceutical and biotech sectors, which had been left out during the semiconductor-driven market rally, are now showing strong performance. The healthcare index is significantly outperforming the semiconductor index, with foreign investors also increasing their buying activity. The easing of U.S. tariff risks and news of global new drug and technology transfers are boosting domestic investor sentiment.

Securities firms predict that this trend will continue through the first half of next year. The global trend toward obesity and metabolic disease treatments, along with domestic companies' technology exports and new drug approvals, are having a positive impact, suggesting there is ample room for further gains. Experts advise, "It is effective to develop a bio investment strategy alongside semiconductors and high-dividend stocks to match the rotational market expected through the end of the year."

원본보기 아이콘

[Go to the No. 1 HiStockLoan in the industry: https://www.hisl.co.kr/5113]

Meanwhile, interest in stock loans continues to grow. Investors who do not want to miss out on rare investment opportunities are turning to stock loans, which allow them to utilize more capital for stock purchases.

Another advantage of stock loans is that even if investors face a forced sale due to a sharp drop in stock prices while using margin or credit, they can easily switch to a stock loan without providing additional collateral or selling their holdings, and then wait for a rebound.

◆ HiStockLoan: Industry’s lowest annual interest rate in the 4% range, offering additional investment funds and credit refinancing!

HiStockLoan has launched a securities-linked credit product with the industry’s lowest annual interest rate in the 4% range, allowing anyone to experience stock loans without burden. It can be used for stock purchases as well as for refinancing margin or credit from securities firms, and is available up to four times the investor’s own capital, regardless of credit rating.

Additionally, for investors who have had difficulty using stock loans due to DSR limits, there are products available that can be used regardless of DSR. Investors using the alternative trading system (NXT) can also take advantage of these offerings.

Investors who want to learn more about HiStockLoan’s wide range of tailored products can contact the customer service center (☎1566-5113) at any time, 24 hours a day, to receive convenient consultation from a specialist, regardless of loan approval.

○ New product launched with industry’s lowest annual interest rate in the 4% range

○ Products available regardless of DSR

○ No. 1 market share for 21 consecutive years, winner of the Korea First Brand Award for 16 consecutive years

○ Real-time repayment of margin/credit from securities firms

○ Trading available on the alternative trading system (NXT)

○ Reliable consultation quality assurance system

* HiStockLoan Consultation Center: 1566-5113

Go to: https://www.hisl.co.kr/5113

ABL Bio, Selvas Healthcare, Samyoung M-Tech, Curiosis, Sena Technology

※ The content above is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.